SC 13D Filing

Company

Vanda Pharmaceuticals Inc.

Filed

October 6, 2008

Accession Number

0001214659-08-002231

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →